Clinical Trials Browser

Terminated × INDUSTRY × pexidartinib × Clear all

NCT02452424 2020-03-05

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Phase 1/2 Terminated

78 enrolled 19 charts

DermatologicGastrointestinalGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Ovarian Neoplasms, Gastrointestinal Stromal Tumors

NCT01499043 2020-03-04

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

Phase 2 Terminated

6 enrolled 6 charts

Prostatic Neoplasms

NCT01349036 2020-03-03

A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma

Phase 2 Terminated

38 enrolled 13 charts

Brain Neoplasms, Glioblastoma